CLEAR CELL RENAL CARCINOMA
Tracking # 20-829437
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
AMONG THE GENITOURINARY CANCERS, RENAL CELL CARCINOMA (RCC) IS THE SEVENTH MOST COMMON CANCER IN MEN AND HAS A HIGH MORTALITY RATE. THE PROGNOSIS OF METASTATIC RCC IS POOR, WITH A MEDIAN SURVIVAL OF ABOUT 13 MONTHS AND 5-YEAR SURVIVAL UNDER 10%. HOWEVER, WITH NEWER THERAPIES, OVERALL SURVIVAL HAS IMPROVED. THIS ACTIVITY REVIEWS THE EVALUATION AND TREATMENT OF CLEAR CELL RENAL CELL CARCINOMA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN EVALUATING AND TREATING THIS CONDITION.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Osteopathic Medicine
Osteopathic Physician
1h
General